Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'SUBCUTANEOUS INTERLEUKIN-2' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 60 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Miller, KD; Spooner, K; Herpin, BR; Rock-Kress, D; Metcalf, JA; Davey, RT; Falloon, J; Kovacs, JA; Polis, RA; Walker, RE; Masur, H; Lane, HC
      Immunotherapy of HIV-infected patients with intermittent interleukin-2: Effects of cycle frequency and cycle duration on degree of CD4(+) T-lymphocyte expansion

      CLINICAL IMMUNOLOGY
    2. Pett, SL; Emery, S
      Immunomodulators as adjunctive therapy for HIV-1 infection

      JOURNAL OF CLINICAL VIROLOGY
    3. Atkins, MB; Dutcher, J; Weiss, G; Margolin, K; Clark, J; Sosman, J; Logan, T; Aronson, F; Mier, J
      Kidney cancer: The Cytokine Working Group experience (1986-2001) - Part I.IL-2-based clinical trials

      MEDICAL ONCOLOGY
    4. De Paoli, P
      Immunological effects of interleukin-2 therapy in human immunodeficiency virus-positive subjects

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    5. Armstrong, WS; Kazanjian, P
      Use of cytokines in human immunodeficiency virus-infected patients: Colony-stimulating factors, erythropoietin, and interleukin-2

      CLINICAL INFECTIOUS DISEASES
    6. Craiu, A; Barouch, DH; Zheng, XX; Kuroda, MJ; Schmitz, JE; Lifton, MA; Steenbeke, TD; Nickerson, CE; Beaudry, K; Frost, JD; Reimann, KA; Strom, TB; Letvin, NL
      An IL-2/Ig fusion protein influences CD4(+) T lymphocytes in naive and simian immunodeficiency virus-infected rhesus monkeys

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    7. Heinzer, H; Huland, E; Huland, H
      Systemic chemotherapy and chemoimmunotherapy for metastatic renal cell cancer

      WORLD JOURNAL OF UROLOGY
    8. Sereti, I; Herpin, B; Metcalf, JA; Stevens, R; Baseler, MW; Hallahan, CW; Kovacs, JA; Davey, RT; Lane, HC
      CD4 T cell expansions are associated with increased apoptosis rates of T lymphocytes during IL-2 cycles in HIV infected patients

      AIDS
    9. Mitsuyasu, RT
      The potential role of interleukin-2 in HIV

      AIDS
    10. Caggiari, L; Zanussi, S; Crepaldi, C; Bortolin, MT; Caffau, C; D'Andrea, M; De Paoli, P
      Different rates of CD4+and CD8+T-cell proliferation in interleukin-2-treated human immunodeficiency virus-positive subjects

      CYTOMETRY
    11. Elias, L; Hunt, WC
      A literature analysis of prognostic factors for response and quality of response of patients with renal cell carcinoma to interleukin-2-based therapy

      ONCOLOGY
    12. Paiardini, M; Galati, D; Cervasi, B; Cannavo, G; Galluzzi, L; Montroni, M; Guetard, D; Magnani, M; Piedimonte, G; Silvestri, G
      Exogenous interleukin-2 administration corrects the cell cycle perturbation of lymphocytes from human immunodeficiency virus-infected individuals

      JOURNAL OF VIROLOGY
    13. David, D; Nait-Ighil, L; Dupont, B; Maral, J; Gachot, B; Theze, J
      Rapid effect of interleukin-2 therapy in human immunodeficiency virus-infected patients whose CD4 cell counts increase only slightly in response to combined antiretroviral treatment

      JOURNAL OF INFECTIOUS DISEASES
    14. Eastman, ME; Khorsand, M; Maki, DG; Williams, EC; Kim, K; Sondel, PM; Schiller, JH; Albertini, MR
      Central venous device-related infection and thrombosis in patients treatedwith moderate dose continuous-infusion interleukin-2

      CANCER
    15. Atzpodien, J; Kirchner, H; Illiger, HJ; Metzner, B; Ukena, D; Schott, H; Funke, PJ; Gramatzki, M; von Jurgensom, S; Wandert, T; Patzelt, T; Reitz, M
      IL-2 in combination with IFN-alpha and 5-FU versus tamoxifen in metastaticrenal cell carcinoma: long-term results of a controlled randomized clinical trial

      BRITISH JOURNAL OF CANCER
    16. Steiner, T; Schubert, J
      Systemic treatment of renal-cell carcinoma: present status

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    17. Sereti, I; Gea-Banacloche, J; Kan, MY; Hallahan, CW; Lane, HC
      Interleukin 2 leads to dose-dependent expression of the alpha chain of theIL-2 receptor on CD25-negative T lymphocytes in the absence of exogenous antigenic stimulation

      CLINICAL IMMUNOLOGY
    18. Pandolfi, F; Pierdominici, M; Marziali, M; Bernandi, ML; Antonelli, G; Galati, V; D'Offizi, G; Aiuti, F
      Low-dose IL-2 reduces lymphocyte apoptosis and increases naive CD4 cells in HIV-1 patients treated with HAART

      CLINICAL IMMUNOLOGY
    19. Vuky, J; Motzer, RJ
      Cytokine therapy in renal cell cancer

      UROLOGIC ONCOLOGY
    20. Dutcher, JP; Logan, T; Gordon, M; Sosman, J; Weiss, G; Margolin, K; Plasse, T; Mier, J; Lotze, M; Clark, J; Atkins, M
      Phase II trial of interleukin 2, interferon alpha, and 5-fluorouracil in metastatic renal cell cancer: A Cytokine Working Group study

      CLINICAL CANCER RESEARCH
    21. Peters, BS
      HIV immunotherapeutic vaccines

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    22. Fraser, C; Ferguson, NM; Ghani, AC; Prins, JM; Lange, JMA; Goudsmit, J; Anderson, RM; de Wolf, F
      Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs

      AIDS
    23. Uittenbogaart, CH; Boscardin, WJ; Anisman-Posner, DJ; Koka, PS; Bristol, G; Zack, JA
      Effect of cytokines on HIV-induced depletion of thymocytes in vivo

      AIDS
    24. Blankson, J; Siliciano, RF
      Interleukin 2 treatment for HIV infection

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    25. Bukowski, RM
      Cytokine combinations: Therapeutic use in patients with advanced renal cell carcinoma

      SEMINARS IN ONCOLOGY
    26. Motzer, RJ; Russo, P
      Systemic therapy for renal cell carcinoma

      JOURNAL OF UROLOGY
    27. Kovacs, JA; Imamichi, H; Vogel, S; Metcalf, JA; Dewar, RL; Baseler, M; Stevens, R; Adelsberger, J; Lambert, L; Davey, RT; Walker, RE; Falloon, J; Polis, MA; Masur, H; Lane, HC
      Effects of intermittent interleukin-2 therapy on plasma and tissue human immunodeficiency virus levels and quasi-species expression

      JOURNAL OF INFECTIOUS DISEASES
    28. Emery, S; Capra, WB; Cooper, DA; Mitsuyasu, RT; Kovacs, JA; Vig, P; Smolskis, M; Saravolatz, LD; Lane, HC; Fyfe, GA; Curtin, PT
      Pooled analysis of 3 randomized, controlled trials of interleukin-2 therapy in adult human immunodeficiency virus type 1 disease

      JOURNAL OF INFECTIOUS DISEASES
    29. van Herpen, CML; Jansen, RLH; Kruit, WHJ; Hoekman, K; Groenewegen, G; Osanto, S; De Mulder, PHM
      Immunochemotherapy with interleukin-2, interferon-alpha and 5-fluorouracilfor progressive metastatic renal cell carcinoma: a multicenter phase II study

      BRITISH JOURNAL OF CANCER
    30. Kaufmann, GR; Zaunders, J; Cooper, DA
      Immune reconstitution in HIV-1 infected subjects treated with potent antiretroviral therapy

      SEXUALLY TRANSMITTED INFECTIONS
    31. Dillman, RO
      What to do with IL-2?

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    32. Ravaud, A; Debled, M
      Present achievements in the medical treatment of metastatic renal cell carcinoma

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    33. Figlin, RA; Thompson, JA; Bukowski, RM; Vogelzang, NJ; Novick, AC; Lange, P; Steinberg, GD; Belldegrun, AS
      Multicenter, randomized, phase III trial of CD8(+) tumor-infiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinoma

      JOURNAL OF CLINICAL ONCOLOGY
    34. Menzel, T; Bergmann, L
      Treatment strategies in metastatic renal cell carcinoma

      ONKOLOGIE
    35. De Paoli, P; Zanussi, S; Caggiari, L; Bortolin, MT; D'Andrea, M; Simonelli, C; Tirelli, U
      Kinetics of lymphokine production in HIV plus patients treated with highlyactive antiretroviral therapy and interleukin 2

      JOURNAL OF CLINICAL IMMUNOLOGY
    36. KARP SE
      LOW-DOSE INTRAVENOUS BOLUS INTERLEUKIN-2 WITH INTERFERON-ALPHA THERAPY FOR METASTATIC MELANOMA AND RENAL-CELL CARCINOMA

      Journal of immunotherapy
    37. ANDRES P; CUPISSOL D; GUILLOT B; AVRIL MF; DRENO B
      SUBCUTANEOUS INTERLEUKIN-2 AND INTERFERON-ALPHA THERAPY ASSOCIATED WITH CISPLATIN MONOCHEMOTHERAPY IN THE TREATMENT OF METASTATIC MELANOMA

      EJD. European journal of dermatology
    38. TONINI G; NUNZIATA C; PRETE SP; PEPPONI R; TURRIZIANI M; MASCI G; GRAZIANI G; BONMASSAR E; DEVECCHIS L
      ADJUVANT TREATMENT OF BREAST-CANCER - A PILOT IMMUNOCHEMOTHERAPY STUDY WITH CMF, INTERLEUKIN-2 AND INTERFERON-ALPHA

      Cancer immunology and immunotherapy
    39. NAGLIERI E; GEBBIA V; DURINI E; LELLI G; ABBATE I; SELVAGGI FP; DITONNO P; COLUCCI G
      STANDARD INTERLEUKIN-2 (IL-2) AND INTERFERON-ALPHA IMMUNOTHERAPY VERSUS AN IL-2 AND 4-EPIRUBICIN IMMUNO-CHEMOTHERAPEUTIC ASSOCIATION IN METASTATIC RENAL-CELL CARCINOMA

      Anticancer research
    40. Pahlavani, MA
      Intervention in the aging immune system: Influence of dietary restriction,dehydroepiandrosterone, melatonin, and exercise

      AGE
    41. DELORD JP; ALEXANDRE J; CHEVREAU C; ESCUDIER B
      ADULT RENAL-CELL CARCINOMA

      Bulletin du cancer
    42. BURNS EA; GOODWIN JS
      IMMUNODEFICIENCY OF AGING

      Drugs & aging
    43. LISSONI P
      EFFECTS OF LOW-DOSE RECOMBINANT INTERLEUKIN-2 IN HUMAN MALIGNANCIES

      The cancer journal from Scientific American
    44. BUKOWSKI RM; OLENCKI T; WANG Q; PEEREBOOM D; BUDD GT; ELSON P; SANDSTROM K; TUASON L; RAYMAN P; TUBBS R; MCLAIN D; KLEIN E; NOVICK A; FINKE J
      PHASE-II TRIAL OF INTERLEUKIN-2 AND INTERFERON-ALPHA IN PATIENTS WITHRENAL-CELL CARCINOMA - CLINICAL-RESULTS AND IMMUNOLOGICAL CORRELATES OF RESPONSE

      Journal of immunotherapy with emphasis on tumor immunology
    45. GUIDA M; LATORRE A; SELVAGGI FP; DITONNO P; LORUSSO V; MASTRIA A; DELENA M
      SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 PLUS ALPHA-INTERFERON AND VINBLASTINE IN METASTATIC RENAL-CELL CARCINOMA - A PHASE-II STUDY

      International journal of oncology
    46. PANZER A; VILJOEN M
      THE VALIDITY OF MELATONIN AS AN ONCOSTATIC AGENT

      Journal of pineal research
    47. PANZER A
      MELATONIN IN OSTEOSARCOMA - AN EFFECTIVE DRUG

      Medical hypotheses
    48. NAGLER A; NAGLER R; ACKERSTEIN A; LEVI S; MARMARY Y
      MAJOR SALIVARY-GLAND DYSFUNCTION IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES RECEIVING INTERLEUKIN-2-BASED IMMUNOTHERAPY POST-AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION (ABSCT)

      Bone marrow transplantation
    49. WALTHER MM; YANG JC; PASS HI; LINEHAN WM; ROSENBERG SA
      CYTOREDUCTIVE SURGERY BEFORE HIGH-DOSE INTERLEUKIN-2 BASED THERAPY INPATIENTS WITH METASTATIC RENAL-CELL CARCINOMA

      The Journal of urology
    50. BUKOWSKI RM
      NATURAL-HISTORY AND THERAPY OF METASTATIC RENAL-CELL CARCINOMA - THE ROLE OF INTERLEUKIN-2

      Cancer
    51. TOURANI JM; GRISE P; LUCAS V; MAYEUR D; DUFOUR B; DIPALMA M; BOAZIZ C; PAVLOVITCH JM; PUJADELAURAINE E; LARREGAIN D; UNTEREINER M
      INTERLEUKIN-2 IN OUTPATIENTS WITH RENAL-CELL CARCINOMA - SCAPP1 TRIAL

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    52. GOEY SH; VERWEIJ J; STOTER G
      IMMUNOTHERAPY OF METASTATIC RENAL-CELL CANCER

      Annals of oncology
    53. VECCHI A; CAVANNA L; AVANZINI P; CALLEA V; VELARDI A; ALBI N; TARTONI P; BENSI L; VALENTINI P; LONGO R; SACCHI S
      IN-VIVO BIOLOGICAL RESPONSE FOLLOWING LOW-DOSE INTERLEUKIN-2 IN COMPLETE REMISSION B-CELL NON-HODGKINS-LYMPHOMA PATIENTS

      European journal of haematology
    54. SHULMAN KL; STADLER WM; VOGELZANG NJ
      HIGH-DOSE CONTINUOUS INTRAVENOUS-INFUSION OF INTERLEUKIN-2 THERAPY FOR METASTATIC RENAL-CELL CARCINOMA - THE UNIVERSITY-OF-CHICAGO EXPERIENCE

      Urology
    55. PROBST M; BUER J; GANSER A; ATZPODIEN J
      INTERLEUKIN-2 IN HEMATOLOGY AND ONCOLOGY - STATE-OF-THE-ART

      The Cancer journal
    56. STADLER WM; VOGELZANG NJ
      LOW-DOSE INTERLEUKIN-2 IN THE TREATMENT OF METASTATIC RENAL-CELL CARCINOMA

      Seminars in oncology
    57. RIDOLFI R; RICCOBON A; FEDRIGA R; PEZZI L; SANTONI A; MALTONI R; FLAMINI E; MILANDRI C; VELOTTI F; AMADORI D
      A PHASE-II STUDY OF ADVANCED COLORECTAL-CANCER PATIENTS TREATED WITH COMBINATION 5-FLUOROURACIL PLUS LEUCOVORIN AND SUBCUTANEOUS INTERLEUKIN-2 PLUS ALPHA-INTERFERON

      Journal of chemotherapy
    58. DALGLEISH AG
      THE ROLE OF IL-2 IN GENE-THERAPY

      Gene therapy
    59. YANG JC; TOPALIAN SL; PARKINSON D; SCHWARTZENTRUBER DJ; WEBER JS; ETTINGHAUSEN SE; WHITE DE; STEINBERG SM; COLE DJ; KIM HI; LEVIN R; GULERIA A; MACFARLANE MP; WHITE RL; EINHORN JH; SEIPP CA; ROSENBERG SA
      RANDOMIZED COMPARISON OF HIGH-DOSE AND LOW-DOSE INTRAVENOUS INTERLEUKIN-2 FOR THE THERAPY OF METASTATIC RENAL-CELL CARCINOMA - AN INTERIM-REPORT

      Journal of clinical oncology
    60. ANDERSON PM; SORENSON MA
      EFFECTS OF ROUTE AND FORMULATION ON CLINICAL PHARMACOKINETICS OF INTERLEUKIN-2

      Clinical pharmacokinetics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/10/20 alle ore 05:57:52